Hikma Pharmaceuticals Plc Stock Technical Analysis
| HKMPY Stock | USD 57.57 1.66 2.97% |
As of the 31st of January, Hikma Pharmaceuticals retains the Risk Adjusted Performance of 0.0872, market risk adjusted performance of 0.4616, and Downside Deviation of 2.24. Hikma Pharmaceuticals technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Hikma Pharmaceuticals Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Hikma, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to HikmaHikma |
Hikma Pharmaceuticals technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Hikma Pharmaceuticals PLC Technical Analysis
The output start index for this execution was fourty-five with a total number of output elements of sixteen. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Hikma Pharmaceuticals PLC volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Hikma Pharmaceuticals PLC Trend Analysis
Use this graph to draw trend lines for Hikma Pharmaceuticals PLC. You can use it to identify possible trend reversals for Hikma Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Hikma Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Hikma Pharmaceuticals Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Hikma Pharmaceuticals PLC applied against its price change over selected period. The best fit line has a slop of 0.11 , which means Hikma Pharmaceuticals PLC will continue generating value for investors. It has 122 observation points and a regression sum of squares at 448.79, which is the sum of squared deviations for the predicted Hikma Pharmaceuticals price change compared to its average price change.About Hikma Pharmaceuticals Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Hikma Pharmaceuticals PLC on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Hikma Pharmaceuticals PLC based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Hikma Pharmaceuticals PLC price pattern first instead of the macroeconomic environment surrounding Hikma Pharmaceuticals PLC. By analyzing Hikma Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Hikma Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Hikma Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
Hikma Pharmaceuticals January 31, 2025 Technical Indicators
Most technical analysis of Hikma help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Hikma from various momentum indicators to cycle indicators. When you analyze Hikma charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0872 | |||
| Market Risk Adjusted Performance | 0.4616 | |||
| Mean Deviation | 1.14 | |||
| Semi Deviation | 1.42 | |||
| Downside Deviation | 2.24 | |||
| Coefficient Of Variation | 1019.64 | |||
| Standard Deviation | 1.75 | |||
| Variance | 3.08 | |||
| Information Ratio | 0.0411 | |||
| Jensen Alpha | 0.1298 | |||
| Total Risk Alpha | (0.03) | |||
| Sortino Ratio | 0.0322 | |||
| Treynor Ratio | 0.4516 | |||
| Maximum Drawdown | 7.75 | |||
| Value At Risk | (3.46) | |||
| Potential Upside | 3.26 | |||
| Downside Variance | 5.02 | |||
| Semi Variance | 2.03 | |||
| Expected Short fall | (1.56) | |||
| Skewness | (0.26) | |||
| Kurtosis | 1.45 |
Additional Tools for Hikma Pink Sheet Analysis
When running Hikma Pharmaceuticals' price analysis, check to measure Hikma Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hikma Pharmaceuticals is operating at the current time. Most of Hikma Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hikma Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hikma Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hikma Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.